Clinilabs is a contract research organization (CRO) that provides early-phase and specialty clinical drug development services to the pharmaceutical, biotechnology, and medical device industries.
Our dedication to early phase and specialty studies is a distinction of importance. We focus on Phase I and II studies that prepare development candidates to move forward into successful Phase III trials. Working within this niche, Clinilabs adds value to clinical drug development programs by executing studies that enable our clients to make informed decisions regarding the viability of new drug candidates. Our goal is to move acceptable candidates forward swiftly and abandon failures early. Simply stated, we maximize our clients’ return on investment.
As a CRO with an international data center and functional alliances on five continents, Clinilabs works with sponsors and other CROs to provide services for development programs of any size. We work with investigator sites across the globe to execute multicenter early phase studies, and we provide specialty services for later phase studies. Our investigator database includes over 1,600 sites with a broad range of capabilities, specialty services, and access to patient populations.
|
